Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2015

Sep 6, 2015

65124_rns_2015-09-06_5d3b0bdf-fc57-4943-8b98-314bcee0e32a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [333 x 175] intentionally omitted <==

MARKET RELEASE

7 September 2015

Imugene Limited

TRADING HALT

The securities of Imugene Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday, 9 September 2015 or when the announcement is released to the market.

Security Code: IMU

Jill Hewitt

SENIOR ADVISER, LISTINGS COMPLIANCE (PERTH)

Sender Phone 08 9224 0013 Sender Email [email protected]

20 Bridge Street Sydney NSW 2000

ASX Compliance Pty Limited ABN 26 087 780 489

www.asx.com.au Customer service 13 12 79

==> picture [175 x 57] intentionally omitted <==

Imugene Limited ACN 009 179 551

7 September 2015

Suite 1, 1233 High Street Armadale VIC 3142

Jill Hewitt ASX Compliance Pty Ltd Perth WA

Dear Jill Hewitt

**Trading

Halt Request**

Pursuant to ASX Listing Rule 17.1, Imugene Limited (Company) requests a trading halt pending an announcement in relation to a proposed capital raising.

The trading halt will remain in place until the earlier of the commencement of normal trading on Wednesday 9 September 2015, or until the release of the announcement in respect of the above matter.

The Company is not aware of any reason why the trading halt should not be granted. Yours faithfully

==> picture [55 x 54] intentionally omitted <==

Justyn Stedwell Company Secretary Imugene Limited

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com